", "sentences": [], "annotations": [], "relations": []}, {"offset": 39063, "infons": {"file": "nihms203815f3.jpg", "id": "F3", "section_type": "FIG", "type": "fig_title_caption"}, "text": "Sulindac Inhibits TNFalpha-induced AKT Activation and tRXRalpha-p85alpha Interaction", "sentences": [], "annotations": [], "relations": []}, {"offset": 39148, "infons": {"file": "nihms203815f3.jpg", "id": "F3", "section_type": "FIG", "type": "fig_caption"}, "text": "(A) Inhibition of AKT activation by Sulindac. The indicated cells starved overnight and treated with Sulindac (100 muM) for 1 hr were analyzed for AKT activation by immunoblotting.", "sentences": [], "annotations": [], "relations": []}, {"offset": 39329, "infons": {"file": "nihms203815f3.jpg", "id": "F3", "section_type": "FIG", "type": "fig_caption"}, "text": "(B) Inhibition of basal AKT activation by RXRalpha siRNA. HepG2 cells transfected with RXRalpha siRNA for 48 hr were treated with Sulindac (100 muM) for 1 hr. AKT activation and RXRalpha expression were analyzed by immunoblotting.", "sentences": [], "annotations": [], "relations": []}, {"offset": 39560, "infons": {"file": "nihms203815f3.jpg", "id": "F3", "section_type": "FIG", "type": "fig_caption"}, "text": "(C) Inhibition of TNFalpha-induced AKT activation by Sulindac and RXRalpha siRNA. A549 lung cancer cells transfected with RXRalpha or control siRNA for 48 hr were pretreated with Sulindac (100 muM) for 1 hr before exposed to TNFalpha (10 ng/ml) for 30 min.", "sentences": [], "annotations": [], "relations": []}, {"offset": 39817, "infons": {"file": "nihms203815f3.jpg", "id": "F3", "section_type": "FIG", "type": "fig_caption"}, "text": "(D) Synergistic inhibition of AKT activation by TNFalpha and Sulindac. ZR-75-1 and PC3 cells were pretreated with Sulindac for 1 hr before exposed to TNFalpha (10 ng/ml) for 30 min.", "sentences": [], "annotations": [], "relations": []}, {"offset": 39999, "infons": {"file": "nihms203815f3.jpg", "id": "F3", "section_type": "FIG", "type": "fig_caption"}, "text": "(E) Induction of RXRalpha-p85alpha interaction by TNFalpha. A549 cells treated with TNFalpha (10 ng/ml) and/or Sulindac (100 muM) for 30 min were analyzed for RXRalpha-p85alpha interaction by co-immunoprecipitation using DeltaN197 antibody. Above, schematic representation of anti-RXRalpha antibodies used in co-immunoprecipitation and immunoblotting assays. D20 antibody recognizes amino acids 2-21 in the N-terminal A/B domain, while DeltaN197 antibody recognizes the C-terminal E/F domain. A RXRalpha truncated protein with about 44 kDa is also shown.", "sentences": [], "annotations": [], "relations": []}, {"offset": 40554, "infons": {"file": "nihms203815f3.jpg", "id": "F3", "section_type": "FIG", "type": "fig_caption"}, "text": "(F) Expression of tRXRalpha in various cancer cell lines. The indicated cell lines treated with or without 9-cis-RA (10-7 M) for 30 min were analyzed by immunoblotting using the DeltaN197 RXRalpha antibody.", "sentences": [], "annotations": [], "relations": []}, {"offset": 40761, "infons": {"file": "nihms203815f3.jpg", "id": "F3", "section_type": "FIG", "type": "fig_caption"}, "text": "One of three to six similar experiments is shown.", "sentences": [], "annotations": [], "relations": []}, {"offset": 40811, "infons": {"file": "nihms203815f3.jpg", "id": "F3", "section_type": "FIG", "type": "fig_caption"}, "text": "See also Figure S3.", "sentences": [], "annotations": [], "relations": []}, {"offset": 40831, "infons": {"file": "nihms203815f4.jpg", "id": "F4", "section_type": "FIG", "type": "fig_title_caption"}, "text": "Role of tRXRalpha in AKT Activation and Anchorage-Independent Cell Growth", "sentences": [], "annotations": [], "relations": []}, {"offset": 40905, "infons": {"file": "nihms203815f4.jpg", "id": "F4", "section_type": "FIG", "type": "fig_caption"}, "text": "(A) Cell density dependent production of tRXRalpha and AKT activation. MEFs seeded at different cell density were analyzed for RXRalpha expression using DeltaN197 antibody and for AKT activation by immunoblotting.", "sentences": [], "annotations": [], "relations": []}, {"offset": 41119, "infons": {"file": "nihms203815f4.jpg", "id": "F4", "section_type": "FIG", "type": "fig_caption"}, "text": "(B) Subcellular localization of endogenous RXRalpha in MEFs was visualized by confocal microscopy after immunostaining using anti-RXRalpha (DeltaN197). Cells were also stained with DAPI to visualize the nucleus. More than 60% of cells showed the images presented.", "sentences": [], "annotations": [], "relations": []}, {"offset": 41383, "infons": {"file": "nihms203815f4.jpg", "id": "F4", "section_type": "FIG", "type": "fig_caption"}, "text": "(C) Stable expression of RXRalpha/1-134 induces RXRalpha cleavage and AKT activation.